Crossmark

Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study

Published Online: 2014-07-08

Authors

Fraticelli, Paolo

Gabrielli, Barbara

Pomponio, Giovanni

Valentini, Gabriele

Bosello, Silvia

Riboldi, Piersandro

Gerosa, Maria

Faggioli, Paola

Giacomelli, Roberto

Del Papa, Nicoletta

Gerli, Roberto

Lunardi, Claudio

Bombardieri, Stefano

Malorni, Walter

Corvetta, Angelo

Moroncini, Gianluca

Gabrielli, Armando
License Information

Text and Data Mining valid from 2014-07-08

Version of Record valid from 2014-07-08
More Information

Article History

Received: 3 February 2014

Accepted: 20 June 2014

First Online: 8 July 2014

Document is current